Conatus Pharmaceuticals Inc. (CNAT)

[biotech2010]

Those are very interesting numbers and even if we extrapolate back (based on the probability of an eventual approval being 10%, which is very, very low) the current market cap should be many multiples of the current share price.

If one considers that TBRA sold for $1B recently why shouldn't CNAT have a similar market cap today? It makes no sense and, at some point, the market will reach equilibrium regarding this, probably when NVS exercises their option in Q2